Engineered T Cell Therapy for Cancer in the Clinic.

Zhao L, Cao YJ. · 2019

Read Engineered T Cell Therapy for Cancer in the Clinic. by Zhao L, Cao YJ. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6798078.txt.

Description

Zhao and Cao review engineered T cell therapy for cancer in the clinic. T cells are central to cell-based immunity in the body. Two strategies reprogram them: CAR T cells, given a synthetic receptor, and TCR T cells, given a new natural-style receptor. Both have produced encouraging results in trials against malignant tumors. Solid tumors remain harder, shielded by dense matrix and suppressive cells.

The article surveys worldwide clinical uses of both therapies in patients. Design details matter for success: adding helper domains such as ICOS and 4-1BB improved cell persistence and anticancer effect in one design. Surface levels of the receptor also shaped how well cells worked. The authors predict engineered T cells will become safe, well-tolerated, and effective standard treatments.

Catalog record

CREATORZhao L, Cao YJ.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6798078

Browse the full library · About the Tower of Babel